ZYBT_OUT_1 [2025-04-28 12:08:23 -0400] 3435 Bytes | 942 tokens | Cum: 942 tkns (11.77% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 12:08 PM on Mon Apr 28, 2025, and I'm firing up the spotlight on Zhengye Biotechnology (ZYBT), moving from $10.44 to $13.03. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

--- COMPANY PROFILE ---
Company: Zhengye Biotechnology (ZYBT)
IPO: 2025-01-07 (3 Months Ago)
Market Cap: $252,122,120
Shares Outstanding: 47,390,000
Exchange: XNAS
Description: Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.

Here’s a list of headlines for Zhengye Biotechnology:

Jan-14-25 12:00PM - Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option
Jan-08-25 12:00PM - Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
Jan-06-25 05:50PM - Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering

Prior AI Reports for ZYBT:
1. 2025-04-16 – Score: 65 – Target: 7.7100 – Highs: 8.0994 / 10.4700 / 11.20
zhengye-biotechnology-soars-amid-sales-decline-high-valuation
2. 2025-04-02 – Score: 1 – Target: 7.6800 – Highs: 7.3500 / 5.4600 / 4.83
high-volume-and-moderate-returns-fuel-optimistic-market-outlook
3. 2025-03-26 – Score: 1 – Target: 9.7000 – Highs: 10.0000 / 7.9894 / 5.67
investor-interest-surges-as-company-shows-remarkable-improvement
4. 2025-03-25 – Score: 1 – Target: 8.6700 – Highs: 9.2793 / 10.0000 / 7.99
zhengye-biotech-soars-amid-strong-momentum-despite-sales-decline
5. 2025-03-21 – Score: 40 – Target: 5.2800 – Highs: 4.9000 / 5.8500 / 9.28
zhengye-biotech-faces-volatility-amidst-dwindling-sales

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Zhengye Biotechnology (ZYBT).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

ZYBT_OUT_3 [2025-04-28 12:08:24 -0400] 907 Bytes | 269 tokens | Cum: 1213 tkns (15.16% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-24T17:05:54Z - 12 Health Care Stocks Moving In Thursday's Intraday Session - CERo Therapeutics Hldgs (NASDAQ:CERO),...
A2 - 2025-04-23T21:05:54Z - 12 Health Care Stocks Moving In Wednesday's After-Market Session - Candel Therapeutics (NASDAQ:CADL)...
A3 - 2025-04-21T17:05:41Z - 12 Health Care Stocks Moving In Monday's Intraday Session - Annovis Bio (NYSE:ANVS), Adagio Medical ...
A4 - 2025-04-16T17:06:28Z - 12 Health Care Stocks Moving In Wednesday's Intraday Session - Biomerica (NASDAQ:BMRA), Acrivon Ther...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ZYBT_OUT_5 [2025-04-28 12:08:25 -0400] 1181 Bytes | 348 tokens | Cum: 1563 tkns (19.54% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**12 Health Care Stocks Moving In Thursday's Intraday Session - CERo Therapeutics Hldgs (NASDAQ:CERO), BioSig Technologies (NASDAQ:BSGM)**Date: 2025-04-24Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/04/44989024/12-health-care-stocks-moving-in-thursdays-intraday-sessionGainers CERo Therapeutics Hldgs CERO stock moved upwards by 37.6% to $1.1 during Thursday's regular session. The company's market cap stands at $5.9 million. TransCode Therapeutics RNAZ shares increased by 26.43% to $0.4. The market value of their outstanding shares is at $9.2 million. Zhengye Biotechnology ZYBT shares increased by 24.8% to $9.76. The market value of their outstanding shares is at $462.5 million. Community Health Sys CYH shares increased by 24.69% to $3.03. The market value of their outstanding shares is at $420.9 million. As pe

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ZYBT_OUT_7 [2025-04-28 12:08:26 -0400] 1181 Bytes | 344 tokens | Cum: 1909 tkns (23.86% of 8k)
==========================================================================

Showing A1 (chunk 2 of 4): r the press release, Q1 earnings came out yesterday. BioSig Technologies BSGM shares increased by 23.43% to $0.79. The market value of their outstanding shares is at $19.1 million. Jaguar Health JAGX shares moved upwards by 19.94% to $8.0. The market value of their outstanding shares is at $5.3 million. Losers NuCana NCNA shares decreased by 26.3% to $0.66 during Thursday's regular session. The company's market cap stands at $3.9 million. Intensity Therapeutics INTS shares decreased by 23.85% to $0.99. The company's market cap stands at $15.0 million. Ensysce Biosciences ENSC shares declined by 16.08% to $3.08. The company's market cap stands at $5.0 million. Metsera MTSR stock fell 15.17% to $20.0. The company's market cap stands at $2.1 billion. Catheter Precision VTAK stock declined by 12.5% to $0.28. The market value of their outstanding shares is at $2.2 million. Plus Therapeutics P

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ZYBT_OUT_9 [2025-04-28 12:08:27 -0400] 1181 Bytes | 386 tokens | Cum: 2297 tkns (28.71% of 8k)
==========================================================================

Showing A1 (chunk 3 of 4): STV shares decreased by 11.41% to $0.87. The market value of their outstanding shares is at $5.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGMBioSig Technologies Inc$0.780021.9%Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock - anytime.

Reveal Full ScoreEdge RankingsMomentum15.59Growth84.23Quality-Value2.67Price TrendShortMediumLongOverviewCEROCERo Therapeutics Holdings Inc$1.1240.1%CYHCommunity Health Systems Inc$3.0224.2%ENSCEnsysce Biosciences Inc$3.08-16.2%INTSIntensity Therapeutics Inc$0.9900-23.9%JAGXJaguar Health Inc$8.1021.4%MTSRMetsera Inc$20.02-15.1%NCNANuCana PLC$0.6587-26.0%PSTVPlus Therapeutics Inc$0.8828-10.2%RNAZTransCode Therapeutics Inc$0.380321.1%VTAKCatheter Precision Inc$0.3038-5.06%ZYBTZhengye Biotechnology

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ZYBT_OUT_11 [2025-04-28 12:08:27 -0400] 357 Bytes | 107 tokens | Cum: 2406 tkns (30.08% of 8k)
==========================================================================

Showing A1 (chunk 4 of 4): Holding Ltd$9.8425.8%Market News and Data brought to you by Benzinga APIs

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ZYBT_OUT_13 [2025-04-28 12:08:28 -0400] 238 Bytes | 59 tokens | Cum: 2467 tkns (30.84% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ZYBT_OUT_15 [2025-04-28 12:08:29 -0400] 251 Bytes | 78 tokens | Cum: 2548 tkns (31.85% of 8k)
==========================================================================

You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source

You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.

ZYBT_OUT_17 [2025-04-28 12:08:35 -0400] 5012 Bytes | 1187 tokens | Cum: 3738 tkns (46.73% of 8k)
==========================================================================

This is our set of metrics for Zhengye Biotechnology.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+------------------------+
| Volume: 76,662 | Perf Month: 133.70% | Option/Short: No / Yes | Sales Y/Y TTM: -28.00% |
+---------------------+-----------------------+------------------------+------------------------+
| Avg Volume: 280.43K | Perf Quarter: 181.07% | Short Float: 2.27% | ROE: 7.51% |
+---------------------+-----------------------+------------------------+------------------------+
| Rel Volume: 0.69 | Index: - | Short Ratio: 0.36 | ROI: 7.24% |
+---------------------+-----------------------+------------------------+------------------------+
| RSI (14): 71.34 | Market Cap: 598.06M | Short Interest: 0.10M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+------------------------+
| ATR (14): 2.05 | Shs Outstand: 47.17M | Beta: - | EPS Surprise: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA20: 92.64% | Shs Float: 4.43M | Sales Q/Q: -21.95% | P/E: 212.10 |
+---------------------+-----------------------+------------------------+------------------------+
| SMA50: 129.51% | Inst Own: - | Sales past 5Y: - | Earnings: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA200: 145.71% | Insider Own: 90.66% | Employees: - | |
+---------------------+-----------------------+------------------------+------------------------+
| Perf Week: 63.90% | Insider Trans: 0.00% | Debt/Eq: 0.31 | |
+---------------------+-----------------------+------------------------+------------------------+

The next section covers any insider trading by Zhengye Biotechnology officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 12.615
Average Volume: 548710.75
30-Day High: 12.615
30-Day Low: 3.64
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Zhengye Biotechnology (ZYBT).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Zhengye Biotechnology.

2) MARKET_SCORE[]
This conversation was initiated because ZYBT is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for ZYBT.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, ZYBT could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect ZYBT to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Zhengye Biotechnology.

11) ETHICAL_RATING[]
Rate Zhengye Biotechnology’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Zhengye Biotechnology.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

ZYBT_IN_19 [2025-04-28 12:08:35 -0400] 126 Bytes | 29 tokens | Cum: 3994 tkns (49.93% of 8k)
==========================================================================

====================================
[2025-04-28 12:08:35] # Analysis Completed
Elapsed Time: 13.05 seconds